NASDAQ:DSCI - Derma Sciences Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $7.00 +7.00 (+∞) (As of 02/27/2017)Previous Close$7.00Today's Range$7.00 - $7.0052-Week Range$2.92 - $7.05VolumeN/AAverage Volume719,592 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileDiscussionChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Derma Sciences, Inc. (Derma Sciences) is a medical device company. The Company operates through two segments: advanced wound care and traditional wound care products. Advanced wound care products principally consist of both novel and otherwise differentiated dressings, devices and skin substitutes designed to promote wound healing and/or prevent infection. The Company's advanced wound care product line consists of MEDIHONEY, TCC-EZ, AMNIOEXCEL and AMNIOMATRIX, XTRASORB and BIOGUARD. Traditional wound care products principally consist of commodity related dressings, ointments, gauze bandages, adhesive bandages, wound closure strips, catheter fasteners and skin care products. The Company's traditional wound care product line includes branded gauze sponges and bandages, non-adherent impregnated dressings, retention devices, paste bandages and other compression devices for the medical markets. Receive DSCI News and Ratings via Email Sign-up to receive the latest news and ratings for DSCI and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry N/A Sub-IndustryHealth Care Supplies SectorN/A Current SymbolNASDAQ:DSCI Previous Symbol CUSIP24982750 CIK892160 Webwww.dermasciences.com Phone+1-609-5144744Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable Derma Sciences (NASDAQ:DSCI) Frequently Asked Questions What is Derma Sciences' stock symbol? Derma Sciences trades on the NASDAQ under the ticker symbol "DSCI." How were Derma Sciences' earnings last quarter? Derma Sciences Inc (NASDAQ:DSCI) released its quarterly earnings results on Tuesday, August, 9th. The medical instruments supplier reported $0.08 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of ($0.08) by $0.16. The medical instruments supplier earned $22.20 million during the quarter, compared to the consensus estimate of $22.40 million. View Derma Sciences' Earnings History. Has Derma Sciences been receiving favorable news coverage? News articles about DSCI stock have been trending positive recently, according to InfoTrie. The research firm identifies negative and positive press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Derma Sciences earned a news impact score of 2.6 on InfoTrie's scale. They also gave press coverage about the medical instruments supplier a news buzz of 3.0 out of 10, meaning that recent press coverage is unlikely to have an effect on the stock's share price in the next few days. What other stocks do shareholders of Derma Sciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other Derma Sciences investors own include Genocea Biosciences (GNCA), Novavax (NVAX), SLS International (SLS), Genetic Technologies (GENE), Idera Pharmaceuticals (IDRA), Progenics Pharmaceuticals (PGNX), Palatin Technologies (PTN), Arbutus Biopharma (ABUS), Allena Pharmaceuticals (ALNA) and Arcturus Therapeutics (ARCT). How do I buy shares of Derma Sciences? Shares of DSCI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Derma Sciences' stock price today? One share of DSCI stock can currently be purchased for approximately $7.00. What is Derma Sciences' official website? The official website for Derma Sciences is http://www.dermasciences.com/. How can I contact Derma Sciences? Derma Sciences' mailing address is 214 Carnegie Ctr Ste 300, PRINCETON, NJ 08540-6237, United States. The medical instruments supplier can be reached via phone at +1-609-5144744. MarketBeat Community Rating for Derma Sciences (NASDAQ DSCI)Community Ranking: 2.9 out of 5 ( )Outperform Votes: 224 (Vote Outperform)Underperform Votes: 159 (Vote Underperform)Total Votes: 383MarketBeat's community ratings are surveys of what our community members think about Derma Sciences and other stocks. Vote "Outperform" if you believe DSCI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DSCI will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 4/20/2019 by MarketBeat.com StaffFeatured Article: What Are Cryptocurrencies?